A detailed history of Asset Management One Co., Ltd. transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Asset Management One Co., Ltd. holds 18,603 shares of CRL stock, worth $3.71 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
18,603
Previous 18,577 0.14%
Holding current value
$3.71 Million
Previous $3.84 Million 4.51%
% of portfolio
0.01%
Previous 0.01%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 30, 2024

BUY
$187.96 - $245.29 $4,886 - $6,377
26 Added 0.14%
18,603 $3.66 Million
Q2 2024

Jul 18, 2024

SELL
$206.39 - $268.73 $39,626 - $51,596
-192 Reduced 1.02%
18,577 $3.84 Million
Q1 2024

May 02, 2024

SELL
$203.52 - $273.43 $212,271 - $285,187
-1,043 Reduced 5.26%
18,769 $5.09 Million
Q4 2023

Jan 24, 2024

SELL
$164.52 - $238.84 $125,199 - $181,757
-761 Reduced 3.7%
19,812 $4.68 Million
Q3 2023

Oct 19, 2023

BUY
$194.44 - $217.61 $286,604 - $320,757
1,474 Added 7.72%
20,573 $4.03 Million
Q2 2023

Jul 31, 2023

SELL
$183.71 - $210.25 $309,183 - $353,850
-1,683 Reduced 8.1%
19,099 $4.02 Million
Q1 2023

Apr 25, 2023

BUY
$191.89 - $259.92 $245,235 - $332,177
1,278 Added 6.55%
20,782 $4.19 Million
Q4 2022

Feb 06, 2023

SELL
$197.11 - $250.07 $88,305 - $112,031
-448 Reduced 2.25%
19,504 $4.25 Million
Q3 2022

Nov 04, 2022

SELL
$182.44 - $250.54 $256,328 - $352,008
-1,405 Reduced 6.58%
19,952 $3.93 Million
Q2 2022

Jul 29, 2022

SELL
$204.13 - $302.4 $245,976 - $364,392
-1,205 Reduced 5.34%
21,357 $4.57 Million
Q1 2022

May 13, 2022

BUY
$255.51 - $362.11 $52,635 - $74,594
206 Added 0.92%
22,562 $6.41 Million
Q4 2021

Feb 09, 2022

SELL
$351.38 - $448.68 $894,262 - $1.14 Million
-2,545 Reduced 10.22%
22,356 $8.35 Million
Q3 2021

Nov 02, 2021

BUY
$372.64 - $458.3 $355,125 - $436,759
953 Added 3.98%
24,901 $10.3 Million
Q2 2021

Aug 03, 2021

BUY
$294.17 - $371.65 $6.34 Million - $8.01 Million
21,550 Added 898.67%
23,948 $8.86 Million
Q1 2021

May 14, 2021

SELL
$249.67 - $299.48 $495,594 - $594,467
-1,985 Reduced 45.29%
2,398 $695,000
Q4 2020

Feb 12, 2021

BUY
$222.0 - $252.62 $14,652 - $16,672
66 Added 1.53%
4,383 $1.09 Million
Q2 2020

Aug 14, 2020

SELL
$118.84 - $189.72 $447,313 - $714,106
-3,764 Reduced 46.58%
4,317 $753,000
Q1 2020

May 14, 2020

BUY
$98.9 - $178.34 $136,580 - $246,287
1,381 Added 20.61%
8,081 $1.02 Million
Q3 2019

Nov 14, 2019

BUY
$125.07 - $143.67 $100,056 - $114,935
800 Added 13.56%
6,700 $887,000
Q2 2019

Aug 14, 2019

SELL
$123.4 - $148.55 $2.32 Million - $2.8 Million
-18,826 Reduced 76.14%
5,900 $837,000
Q1 2019

May 15, 2019

BUY
$104.82 - $146.73 $2.59 Million - $3.63 Million
24,726 New
24,726 $3.59 Million

Others Institutions Holding CRL

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.


  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $10.2B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Asset Management One Co., Ltd. Portfolio

Follow Asset Management One Co., Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Asset Management One Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Asset Management One Co., Ltd. with notifications on news.